ONCOTHERAPY SCIENCE INC chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 7.56
Dividend & YieldN/A¥ (N/A)
Beta 0.82
Market capitalization 11.94B
Operating cash flow N/A
ESG Scores unknown

Company description

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as well as in Phase II clinical trials for the treatment of bladder cancer; S-488210 that is in Phase I/II clinical trials for the treatment of head and neck cancer; and S-588210, which is in Phase I clinical trials for the treatment of solid tumor. In addition, it is developing antibody drugs consisting of OTSA101, which is in Phase I clinical trials for synovial sarcoma; and KHK6640, an anti-amyloid beta peptide antibody that is Phase I clinical trials for Alzheimer's disease. Further, the company provides contract analysis services. OncoTherapy Science, Inc. was founded in 2001 and is headquartered in Kawasaki, Japan.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities 87M -128M -39M 385M
Total Cashflows From Investing Activities -74M -30M -52M -467M
Net Borrowings
Total Cash From Financing Activities 565M 2.16B 1.48B 1.48B
Change To Operating Activities 55M -51M -80M -12M
Issuance Of Stock 565M 2.16B 1.48B 1.48B
Net Income -2.93B -2.24B -1.56B -2.57B
Change In Cash -1.88B -143M -1.81B -1.06B
Effect Of Exchange Rate -1M -1M
Total Cash From Operating Activities -2.37B -2.27B -1.76B -2.07B
Depreciation 391M 39M 49M 16M
Change To Account Receivables -16M -12M -123M -247M
Other Cashflows From Financing Activities
Change To Netincome 314M 113M 7M 544M
Capital Expenditures -71M -130M -43M -456M

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development
Income Before Tax -3.19B -2.24B -1.56B -2.57B
Net Income -2.93B -2.24B -1.56B -2.57B
Selling General Administrative 296M 271M 281M 294M
Gross Profit -2.55B -1.79B -1.36B -1.62B
Ebit -2.95B -2.19B -1.64B -2.05B
Operating Income -2.95B -2.19B -1.64B -2.05B
Interest Expense
Income Tax Expense -2M 1M 1M 1M
Total Revenue 280M 316M 332M 1.15B
Cost Of Revenue 2.83B 2.11B 1.69B 2.77B
Total Other Income ExpenseNet -238M -48M 78M -517M
Net Income From Continuing Ops -3.19B -2.24B -1.56B -2.57B
Net Income Applicable To Common Shares -2.93B -2.24B -1.56B -2.57B

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 498M 361M 293M 706M
Total Stockholder Equity 4.87B 4.73B 3.08B 1.98B
Other Current Liabilities 367M 242M 194M 604M
Total Assets 5.37B 5.09B 3.37B 2.69B
Common Stock 328M 1.42B 50M 789M
Other Current Assets 156M 112M 102M 134M
Retained Earnings -17.31B -19.55B -21.11B -23.69B
Treasury Stock 264M 176M 85M 83M
Cash 4.86B 4.71B 2.9B 1.84B
Total Current Liabilities 367M 242M 194M 604M
Other Stockholder Equity 264M 176M 85M 83M
Property, Plant, and Equipment 200M 113M 94M
Total Current Assets 5.05B 4.88B 3.19B 2.6B
Net Tangible Assets 4.86B 4.72B 3.07B 1.98B
Net Receivables 17M 29M 152M 399M
Accounts Payable


Insider Transactions

Here are the insider transactions of stock shares related to ONCOTHERAPY SCIENCE INC:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to ONCOTHERAPY SCIENCE INC. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on ONCOTHERAPY SCIENCE INC

Here is the result of two systematic investment strategies applied to ONCOTHERAPY SCIENCE INC. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on ONCOTHERAPY SCIENCE INC

The following chart shows the equity curve of the two systematic investment strategies applied to ONCOTHERAPY SCIENCE INC:

ONCOTHERAPY SCIENCE INC automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -5.75% on the backtest period.

Performance at glance

Performance

-5.75 %

Latent gain

-141.0 ¥

Invested capital

2453.0 ¥

Annualized return

-1.37 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on ONCOTHERAPY SCIENCE INC

This is the result of two momentum investment strategies applied to ONCOTHERAPY SCIENCE INC. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on ONCOTHERAPY SCIENCE INC

The following chart shows all the entries opened by the momentum investment system on ONCOTHERAPY SCIENCE INC:

ONCOTHERAPY SCIENCE INC momentum entries
  • The first momentum investment strategy would give -2.0% of return on ONCOTHERAPY SCIENCE INC. That represents -97.0¥ of latent gain with 4857.0¥ of employed capital.
  • The second momentum investment strategy would give -1.9% of return on ONCOTHERAPY SCIENCE INC. That represents -66.0¥ of latent gain with 3466.0¥ of employed capital.
Performance at glance (1Q Momentum)

Performance

-2.0 %

Latent gain

-97.0 ¥

Invested capital

4857.0 ¥

Annualized return

4.4 %
Performance at glance (2Q Momentum)

Performance

-1.9 %

Latent gain

-66.0 ¥

Invested capital

3466.0 ¥

Annualized return

-0.51 %

Momentum equity curve on ONCOTHERAPY SCIENCE INC

The following chart shows the equity curve of the two momentum strategies applied to ONCOTHERAPY SCIENCE INC:

ONCOTHERAPY SCIENCE INC momentum equity

Note: the dividends potentially given by ONCOTHERAPY SCIENCE INC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ONCOTHERAPY SCIENCE INC

The following chart shows the employed capital evolution of the two momentum strategies on ONCOTHERAPY SCIENCE INC since the beginning:

ONCOTHERAPY SCIENCE INC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250¥, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000¥.


Buy the dip strategy result on ONCOTHERAPY SCIENCE INC

Buy the dip entry openings on ONCOTHERAPY SCIENCE INC

ONCOTHERAPY SCIENCE INC

The performance achieved by the robo-advisor on ONCOTHERAPY SCIENCE INC is 9.68%. That represents 48.0$ of latent gain with 496.0¥ of employed capital. The following chart shows ONCOTHERAPY SCIENCE INC stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of ONCOTHERAPY SCIENCE INC, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

9.68 %

Latent gain

48.0 ¥

Invested capital

496.0 ¥

Annualized return

4.4 %

Equity curve of the strategy applied to ONCOTHERAPY SCIENCE INC

The following chart shows the result of the investment strategy applied to ONCOTHERAPY SCIENCE INC:

ONCOTHERAPY SCIENCE INC

Note: the dividends potentially given by ONCOTHERAPY SCIENCE INC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ONCOTHERAPY SCIENCE INC

The following chart shows the employed capital evolution since the beginning of the investment strategy on ONCOTHERAPY SCIENCE INC:

ONCOTHERAPY SCIENCE INC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on ONCOTHERAPY SCIENCE INC

In this section, I will compare the three previous investment strategies applied to ONCOTHERAPY SCIENCE INC.

Equity curve comparison on ONCOTHERAPY SCIENCE INC

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

ONCOTHERAPY SCIENCE INC investment strategy comparison

Employed capital comparison on ONCOTHERAPY SCIENCE INC

ONCOTHERAPY SCIENCE INC investment comparison

Performance comparison on ONCOTHERAPY SCIENCE INC

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -5.75% -141.0¥ 2453.0¥ -1.37%
Momentum 1 quarter -2.0% -97.0¥ 4857.0¥ -0.51%
Momentum 2 quarters -1.9% -66.0¥ 3466.0¥ -0.51%
Non-directional 9.68% 48.0¥ 496.0¥ 4.4%
Annualized return comparison

Automatic investment

-1.37 %

Momentum 1Q

-0.51 %

Momentum 2Q

-0.51 %

Non-directional

4.4 %

Correlated stocks

Here are the most positively and negatively correlated stocks with ONCOTHERAPY SCIENCE INC:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between ONCOTHERAPY SCIENCE INC and the other stocks. There may be false positives or some missing correlated stocks. If the price of ONCOTHERAPY SCIENCE INC does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name ONCOTHERAPY SCIENCE INC
Country Japan
City Kawasaki
Address 3-2-1 Sakado
Phone 81 44 820 8251
Website www.oncotherapy.co.jp
FullTime employees 67
Industry Biotechnology
Sector Healthcare
Exchange XTKS
Ticker 4564.XTKS
Market www.jpx.co.jp

ONCOTHERAPY SCIENCE INC ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown